Drug profile · INN
somatropin recombinant
ZORBTIVE
somatropin recombinant (ZORBTIVE) is a growth hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — somatropin recombinant
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
somatropin recombinant (ZORBTIVE) is a growth hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Growth hormone receptor agonist
Primary target: Growth hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is somatropin recombinant?
somatropin recombinant (ZORBTIVE) is a growth hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for somatropin recombinant?
ZORBTIVE is a marketed brand name for somatropin recombinant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of somatropin recombinant?
somatropin recombinant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.